St. Jude Medical Inc.is working with FDA to design a new U.S. pivotal trial of its EnligHTN multielectrode renal denervation system for patients with drug-resistant high blood pressure after patient-enrollment problems led it to discontinue the sham-controlled EnligHTN IV
trial.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?